Capital Cell is Europe’s first life sciences equity crowdfunding platform. Life sciences is one of the most profitable investment sectors in the world, but traditionally investment in life sciences companies has only been accessible to a small group of people with a high level of technical expertise and large sums to invest. Capital Cell opens life science investment to everyone by sourcing and screening the most innovative early-stage life science companies, and presenting them to the crowd through a regulated online investment platform. Capital Cell finances companies across the life science sector, including therapeutics, medical devices, services, bioinformatics, and software. Capital Cell redefines life science investment, and through supporting scientific innovation, funds projects that change lives.